MetLife, Inc.
MET
$69.61
-$6.30-8.30%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -0.10% | -8.75% | 9.64% | 9.33% | 8.22% |
Total Other Revenue | -377.47% | -359.87% | -142.64% | -109.49% | -106.69% |
Total Revenue | -2.71% | -13.34% | 2.98% | -3.07% | -3.26% |
Cost of Revenue | 2.94% | -21.61% | 1.23% | 0.54% | 0.36% |
Gross Profit | -18.38% | 20.05% | 8.43% | -11.81% | -12.05% |
SG&A Expenses | -- | -- | -- | -- | -- |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 6.81% | 2.76% | -2.71% | -4.16% | -6.40% |
Total Operating Expenses | 3.63% | -17.72% | 0.51% | -0.34% | -0.92% |
Operating Income | -56.11% | 76.81% | 34.14% | -21.30% | -19.33% |
Income Before Tax | -66.03% | -42.47% | -34.17% | -52.04% | -21.68% |
Income Tax Expenses | -47.27% | -4.78% | -3.27% | -51.12% | -31.53% |
Earnings from Continuing Operations | -69.78% | -47.91% | -39.47% | -52.26% | -19.36% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -33.33% | 4.76% | 9.52% | 14.29% | 14.29% |
Net Income | -70.14% | -48.10% | -39.58% | -52.36% | -19.38% |
EBIT | -56.11% | 76.81% | 34.14% | -21.30% | -19.33% |
EBITDA | -50.80% | 73.25% | 35.19% | -18.08% | -16.15% |
EPS Basic | -71.03% | -47.42% | -37.58% | -50.12% | -13.77% |
Normalized Basic EPS | -64.19% | -39.61% | -30.23% | -48.42% | -15.78% |
EPS Diluted | -70.98% | -47.34% | -37.57% | -50.14% | -13.93% |
Normalized Diluted EPS | -64.15% | -39.59% | -30.18% | -48.38% | -15.75% |
Average Basic Shares Outstanding | -5.67% | -5.83% | -6.17% | -6.64% | -6.90% |
Average Diluted Shares Outstanding | -5.75% | -5.91% | -6.26% | -6.73% | -6.97% |
Dividend Per Share | 4.04% | 4.08% | 4.12% | 4.17% | 4.21% |
Payout Ratio | 2.31% | 0.90% | 0.62% | 1.04% | 0.20% |